Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 389

Similar articles for PubMed (Select 19692433)

1.

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.

Weber-Schoendorfer C, Schaefer C.

Mult Scler. 2009 Sep;15(9):1037-42. doi: 10.1177/1352458509106543.

PMID:
19692433
2.

The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.

Boskovic R, Wide R, Wolpin J, Bauer DJ, Koren G.

Neurology. 2005 Sep 27;65(6):807-11. Erratum in: Neurology. 2005 Dec 27;65(12):1992.

PMID:
16186517
3.

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.

Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Piscolla E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La Mantia L, Mancardi G, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP.

BMC Neurol. 2012 Oct 22;12:124. doi: 10.1186/1471-2377-12-124.

4.

Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).

Fernández Liguori N, Klajn D, Acion L, Cáceres F, Calle A, Carrá A, Cristiano E, Deri N, Garcea O, Jaureguiberry A, Onaha P, Patrucco L, Riccio P, Rotta Escalante R, Saladino Ml, Sinay V, Tarulla A, Villa A.

Mult Scler. 2009 May;15(5):555-62. doi: 10.1177/1352458509102366. Epub 2009 Mar 19.

PMID:
19299437
5.

Parenthood and immunomodulation in patients with multiple sclerosis.

Hellwig K, Haghikia A, Gold R.

J Neurol. 2010 Apr;257(4):580-3. doi: 10.1007/s00415-009-5376-z. Epub 2009 Nov 21.

PMID:
19936821
6.

Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.

Djulus J, Koren G, Einarson TR, Wilton L, Shakir S, Diav-Citrin O, Kennedy D, Voyer Lavigne S, De Santis M, Einarson A.

J Clin Psychiatry. 2006 Aug;67(8):1280-4.

PMID:
16965209
7.

Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patients.

Castelli-Haley J, Oleen-Burkey M, Lage MJ, Johnson KP.

Adv Ther. 2008 Jul;25(7):658-73. doi: 10.1007/s12325-008-0077-z. Erratum in: Adv Ther. 2008 Aug;25(8):830. Oleen-Burkey, Merry-Kay A [corrected to Oleen-Burkey, MerriKay].

PMID:
18641926
8.

Interferon beta, birth weight and pregnancy in multiple sclerosis.

Hellwig K, Agne H, Gold R.

J Neurol. 2009 May;256(5):830-1. doi: 10.1007/s00415-009-5014-9. Epub 2009 Feb 25. No abstract available.

PMID:
19240959
9.

Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis.

Giovannoni G, Barbarash O, Casset-Semanaz F, Jaber A, King J, Metz L, Pardo G, Simsarian J, Sørensen PS, Stubinski B; RNF Study Group.

Clin Ther. 2007 Jun;29(6):1128-45.

PMID:
17692727
10.

Glatiramer acetate in treatment-naïve and prior interferon-beta-1b-treated multiple sclerosis patients.

Zwibel HL; Copolymer-1 Treatment Study Principal Investigators.

Acta Neurol Scand. 2006 Jun;113(6):378-86.

PMID:
16674604
11.

The safety of cetirizine during pregnancy. A prospective observational cohort study.

Weber-Schoendorfer C, Schaefer C.

Reprod Toxicol. 2008 Sep;26(1):19-23. doi: 10.1016/j.reprotox.2008.05.053. Epub 2008 May 13.

PMID:
18571373
12.

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A.

J Clin Psychiatry. 2005 Apr;66(4):444-9; quiz 546.

PMID:
15816786
13.

The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.

Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert-Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C.

Reprod Toxicol. 2008 Sep;26(1):24-30. doi: 10.1016/j.reprotox.2008.05.065. Epub 2008 Jun 7.

PMID:
18585452
14.

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.

Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, Chang P, Francis GS.

Neurology. 2005 Sep 27;65(6):802-6. Epub 2005 Aug 10. Review.

PMID:
16093457
15.

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.

Amato MP, Portaccio E, Ghezzi A, Hakiki B, Zipoli V, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, Di Tommaso V, Paolicelli D, Marrosu MG, Comi G, Pellegrini F, Trojano M; MS Study Group of the Italian Neurological Society.

Neurology. 2010 Nov 16;75(20):1794-802. doi: 10.1212/WNL.0b013e3181fd62bb.

PMID:
21079181
16.

Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?

Patti F, Cavallaro T, Lo Fermo S, Nicoletti A, Cimino V, Vecchio R, Laisa P, Zarbo R, Zappia M.

J Neurol. 2008 Aug;255(8):1250-3. doi: 10.1007/s00415-008-0909-4. Epub 2008 Jul 28.

PMID:
18677640
17.

Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis.

Monzani F, Meucci G, Caraccio N, Saviozzi M, Casolaro A, Moscato G, Lombardo F, Mosti S, Scagnolari C, Bruschi F, Antonelli G, Ferrannini E, Murri L.

J Interferon Cytokine Res. 2002 Jul;22(7):773-81.

PMID:
12184915
18.

Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.

Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, Clementi M, Ornoy A.

J Clin Psychiatry. 2005 Mar;66(3):317-22.

PMID:
15766297
19.

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

Lu E, Wang BW, Guimond C, Synnes A, Sadovnick D, Tremlett H.

Neurology. 2012 Sep 11;79(11):1130-5. doi: 10.1212/WNL.0b013e3182698c64. Epub 2012 Aug 29. Review.

20.

Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.

Bar-Oz B, Moretti ME, Bishai R, Mareels G, Van Tittelboom T, Verspeelt J, Koren G.

Am J Obstet Gynecol. 2000 Sep;183(3):617-20.

PMID:
10992182
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk